Incorporation of chimeric HIV-SIV-Env and modified HIV-Env proteins into HIV pseudovirions

Virology

Volumn 361, Issue 2, 2007, Pages 465-471

  Devitt, Gerard ^a   Emerson, Vanessa ^a   Holtkotte, Denise ^a   Pfeiffer, Tanya ^a   Pisch, Thorsten ^a   Bosch, Valerie ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

HIV glycoprotein incorporation; HIV Env truncation; Pseudovirion; SIV Env truncation

Indexed keywords

CHIMERIC PROTEIN; VACCINE; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; CELL FUSION; CELL SURFACE; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN IMMUNODEFICIENCY VIRUS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; VIRION;

CELL LINE; GLYCOPROTEINS; HIV; HUMANS; MUTATION; REASSORTANT VIRUSES; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSFECTION; VIRAL ENVELOPE PROTEINS; VIRION; VIRULENCE; VIRUS INACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 34247119089     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.11.029     Document Type: Article

References (30)

1. Abacioglu Y.H., Fouts T.R., Laman J.D., Claassen E., Pincus S.H., Moore J.P., Roby C.A., Kamin-Lewis R., and Lewis G.K. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res. Hum. Retroviruses 10 4 (1994) 371-381
2. Adachi A., Gendelman H.E., Koenig S., Folks T., Willey R., Rabson A., and Martin M.A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59 2 (1986) 284-291
3. Bastiani L., Laal S., Kim M., and Zolla-Pazner S. Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions. J. Virol. 71 5 (1997) 3444-3450
4. Burton D.R., Desrosiers R.C., Doms R.W., Koff W.C., Kwong P.D., Moore J.P., Nabel G.J., Sodroski J., Wilson I.A., and Wyatt R.T. HIV vaccine design and the neutralizing antibody problem. Nat. Immunol. 5 3 (2004) 233-236
5. Chertova E., Bess Jr. J.W., Crise B.J., Sowder I.R., Schaden T.M., Hilburn J.M., Hoxie J.A., Benveniste R.E., Lifson J.D., Henderson L.E., and Arthur L.O. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus. J. Virol. 76 11 (2002) 5315-5325
6. Chesebro B., Wehrly K., Nishio J., and Perryman S. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66 11 (1992) 6547-6554
7. Cosson P. Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J. 15 21 (1996) 5783-5788
8. Freed E.O., and Martin M.A. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69 3 (1995) 1984-1989
9. Freed E.O., and Martin M.A. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70 1 (1996) 341-351
10. Hahn B.H., Shaw G.M., Arya S.K., Popovic M., Gallo R.C., and Wong-Staal F. Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature 312 5990 (1984) 166-169
11. Holtkotte D., Pfeiffer T., Pisch T., and Bosch V. Selection and characterization of a replication-competent human immunodeficiency virus type 1 variant encoding C-terminally truncated env. AIDS Res. Hum. Retroviruses 22 1 (2006) 57-65
12. Kestler H., Kodama T., Ringler D., Marthas M., Pedersen N., Lackner A., Regier D., Sehgal P., Daniel M., and King N. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248 4959 (1990) 1109-1112
13. Lampe, M., Briggs, J.A.G., Endress, T., Glass, B., Riegelsberger, S., Kräusslich, H.G., Lamb, D.C., Bräuchle, C., Müller, B., in press. Double-labelled HIV-1 particles for study of virus-cell interaction. Virology. [Electronic publication ahead of print].
14. Lasky L.A., Groopman J.E., Fennie C.W., Benz P.M., Capon D.J., Dowbenko D.J., Nakamura G.R., Nunes W.M., Renz M.E., and Berman P.W. Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Science 233 4760 (1986) 209-212
15. Lopez-Verges S., Camus G., Blot G., Beauvoir R., Benarous R., and Berlioz-Torrent C. Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions. Proc. Natl. Acad. Sci. U. S. A. 103 40 (2006) 14947-14952
16. Louder M.K., Sambor A., Chertova E., Hunte T., Barrett S., Ojong F., Sanders-Buell E., Zolla-Pazner S., McCutchan F.E., Roser J.D., Gabuzda D., Lifson J.D., and Mascola J.R. HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity. Virology 339 2 (2005) 226-238
17. Mammano F., Kondo E., Sodroski J., Bukovsky A., and Gottlinger H.G. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 69 6 (1995) 3824-3830
18. Mammano F., Salvatori F., Indraccolo S., De Rossi A., Chieco-Bianchi L., and Gottlinger H.G. Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells. J. Virol. 71 4 (1997) 3341-3345
19. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., and Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 5259 (1996) 263-267
20. Ono A., and Freed E.O. Role of lipid rafts in virus replication. Adv. Virus Res. 64 (2005) 311-358
21. Pantophlet R., and Burton D.R. GP120: target for neutralizing HIV-1 antibodies. Annu. Rev. Immunol. 24 (2006) 739-769
22. Schnierle B.S., Stitz J., Bosch V., Nocken F., Merget-Millitzer H., Engelstadter M., Kurth R., Groner B., and Cichutek K. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc. Natl. Acad. Sci. U. S. A. 94 16 (1997) 8640-8645
23. Schwartz S., Felber B.K., and Pavlakis G.N. Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs. Mol. Cell. Biol. 12 1 (1992) 207-219
24. Spies C.P., and Compans R.W. Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein. Virology 203 1 (1994) 8-19
25. Wilk T., Pfeiffer T., and Bosch V. Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology 189 1 (1992) 167-177
26. Wyma D.J., Kotov A., and Aiken C. Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles. J. Virol. 74 20 (2000) 9381-9387
27. Yuste E., Reeves J.D., Doms R.W., and Desrosiers R.C. Modulation of Env content in virions of simian immunodeficiency virus: correlation with cell surface expression and virion infectivity. J. Virol. 78 13 (2004) 6775-6785
28. Zhu P., Chertova E., Bess Jr. J., Lifson J.D., Arthur L.O., Liu J., Taylor K.A., and Roux K.H. Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions. Proc. Natl. Acad. Sci. U.S.A. 100 26 (2003) 15812-15817
29. Zhu P., Liu J., Bess J., Chertova E., Lifson J.D., Grise H., Ofek G.A., Taylor K.A., and Roux K.H. Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441 7095 (2006) 847-852
30. Zingler K., and Littman D.R. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and fusogenicity and infectivity. J. Virol. 67 5 (1993) 2824-2831